TP53 and colon carcinoma: Activation of JNK in these studies was described as only a downstream event of p53 and inhibition of endogenous JNK activity resulted in an increase of apoptosis in response to nocodazole treatment of human colon carcinoma cells harboring wild type p53 in the latter studies [36].